Barton Shane sold BIOA
June 30, 2026 · Form 4 insider transaction
Barton Shane sold 20,216 shares of BioAge Labs, Inc. at $25.19 per share, a transaction worth $509.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
20,216
Price
$25.19
Total value
$509.2K
InsiderBarton Shane
RoleOfficer
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 30, 2026
Filing dateJuly 1, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.42 per share, inclusive.